⌘K

Home/Filings/4/0001415889-22-010764

4//SEC Filing

Colpman David 4

Accession 0001415889-22-010764

CIK 0001708527other

View on SEC.gov Company Profile

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 4:54 PM ET

Size

5.4 KB

Accession

0001415889-22-010764

Insider Transaction Report

Form 4

Period: 2022-10-20

AZIYO BIOLOGICS, INC.AZYO

Director

Transactions

Award
Stock Option (Right to Buy)
2022-10-20+28,513→ 28,513 total
Exercise: $7.16Exp: 2032-10-20→ Class A Common Stock (28,513 underlying)

Footnotes (1)

[F1]The option vests annually in three equal installments of one-third each, on each of the first three anniversaries of the grant date, such that the option shall be fully vested and exercisable on October 20, 2025.

Documents

1 file

4
form4-10242022_011032.xmlPrimary

Issuer

AZIYO BIOLOGICS, INC.

CIK 0001708527

Entity typeother

Related Parties

1

filerCIK 0001818776

Filing Metadata

Form type: 4
Filed: Oct 23, 8:00 PM ET
Accepted: Oct 24, 4:54 PM ET
Size: 5.4 KB

View on SEC.gov